Camurus' FDA accepts CAM2029 NDA resubmission for acromegaly, sets December decision date

Raidium introduces AI-powered oncology imaging workflow for US cancer centres

World Health Organization approves 'codabakalner' as International Nonproprietary Name for Spinogenix's SPG601

Circio and Avenue Biosciences launch research collaboration to improve protein secretion for gene therapy

Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones

Lakewood-Amedex Biotherapeutics reports positive Nu-3 Gel preclinical safety data for upcoming Phase 2a trial

MAXONA Pharmaceuticals' Phase 2 clinical trial IND application for MAX-001 cleared by US FDA

Kalohexis presents dual MC3R/MC4R activation data at ICO 2026

Merck reports positive Phase 3 results for KEYTRUDA in advanced endometrial cancer

Bruker expands infection diagnostics portfolio with DISQVER platform acquisition

FDA grants priority review to Genentech's Gazyva for primary membranous nephropathy

Lynk Pharmaceuticals completes patient enrolment for zemprocitinib Phase III clinical trial in ankylosing spondylitis

Kelun-Biotech's Phase III study of sac-TMT in combination with pembrolizumab meets primary endpoint

AstraZeneca signs global licence deal with Dizal for lung cancer drug Zegfrovy

Summit Therapeutics sells Phase III antibiotic asset ridinilazole to Biossil